Effect of magnesium sulfate on renal colic pain: A PRISMA-compliant meta-analysis

Liang Fu Chen, Chih Hao Yang, Ting Yi Lin, Po Jia Pao, Karen Chia Wen Chu, Chin Wang Hsu, Chyi Huey Bai, Ming Hai Du, Yuan Pin Hsu

研究成果: 雜誌貢獻文章同行評審

4 引文 斯高帕斯(Scopus)


BACKGROUND: Magnesium sulfate (MgSO4) is widely used in analgesia for different conditions. Recent randomized controlled trials (RCTs) have evaluated the effects of MgSO4 on renal colic; however, this new evidence has not been synthesized. Thus, we conducted a systematic review and meta-analysis to assess the efficacy and safety of MgSO4 in comparison with control for renal colic. METHODS: PubMed, EMBASE, and Scopus databases were searched from inception to February 2020. We included RCTs that evaluated MgSO4 vs control for patients with renal colic. Data were independently extracted by 2 reviewers and synthesized using a random-effects model. RESULTS: Four studies with a total of 373 patients were analyzed. Intravenous MgSO4 15 to 50 mg/kg did not significantly reduce renal colic pain severity at 15 minutes (mean difference [MD] = 0.35, 95% confidence interval [CI] -0.51 to 1.21; 2 RCTs), 30 minutes (MD = 0.19, 95% CI -0.74 to 1.13; 4 RCTs), and 60 minutes (MD = -0.28, 95% CI -0.72 to 0.16; 3 RCTs) in comparison with controls. In patients who failed to respond to initial analgesics, intravenous MgSO4 15 mg/kg or 2 ml of 50% solution provided similar pain relief to ketorolac or morphine at 30 minutes (P = .90) and 60 minutes (P = .57). No significant hemodynamic changes were observed with short-term use of MgSO4 in these studies. CONCLUSION: MgSO4 provides no superior therapeutic benefits in comparison with control treatments. MgSO4 may be used as a rescue medication in patients not responding to initial analgesics. The short-term use of MgSO4 did not affect hemodynamic values.

頁(從 - 到)e23279
出版狀態已發佈 - 11月 13 2020

ASJC Scopus subject areas

  • 醫藥 (全部)


深入研究「Effect of magnesium sulfate on renal colic pain: A PRISMA-compliant meta-analysis」主題。共同形成了獨特的指紋。